[Amyloidosis in children with rheumatoid arthritis and the results of its long-term treatment with colchicine]. 1991

S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova

The authors provide materials of a clinical follow-up of 23 children suffering from rheumatoid arthritis (RA) with an outcome of amyloidosis of the internal organs, supported by morphological examination in 13 patients. 10 patients were treated with colchicine in a dose of 1-2 mg/day lasting from 6 months to 2 years and 7 months. The beneficial effect was attained in 7 children. In 3 patients with RA standing over 8 years, the results were negative. Colchicine merits attention as an effective drug for the treatment of secondary amyloidosis in RA patients.

UI MeSH Term Description Entries
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000686 Amyloidosis A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits. Amyloidoses

Related Publications

S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
January 1990, Terapevticheskii arkhiv,
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
August 1986, Ryumachi. [Rheumatism],
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
April 1979, Annals of the rheumatic diseases,
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
January 1987, European journal of rheumatology and inflammation,
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
January 1956, Acta medica Scandinavica. Supplementum,
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
July 2006, Clinical rheumatology,
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
June 2009, Autoimmunity reviews,
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
January 1977, La Clinica terapeutica,
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
January 2013, Open access rheumatology : research and reviews,
S I Iandashevskaia, and A A Iakovleva, and G M Dvoriakovskaia, and L G Sibiriakova
July 1987, Clinical orthopaedics and related research,
Copied contents to your clipboard!